Ignite Creation Date:
2025-12-24 @ 5:10 PM
Ignite Modification Date:
2026-01-25 @ 5:58 AM
Study NCT ID:
NCT02817750
Status:
COMPLETED
Last Update Posted:
2018-06-11
First Post:
2016-06-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 3.5 mg Formulation
Sponsor:
Biolab Sanus Farmaceutica
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-05
Start Date Type:
ACTUAL
Primary Completion Date:
2018-02-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-02-22
Completion Date Type:
ACTUAL
First Submit Date:
2016-06-27
First Submit QC Date:
None
Study First Post Date:
2016-06-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-06-07
Last Update Post Date:
2018-06-11
Last Update Post Date Type:
ACTUAL